JNJ Stock a Top Dividend Name for 2016 and Beyond Johnson 38; Johnson (NYSE:JNJ) is an old stalwart, known for being one of the most reliable stocks for dividend investors. It is among an elite class of companies that have increased …
Johnson & Johnson (NYSE: JNJ) has increased the amount of money it returns to investors in the form of dividends every year for more than 50 years. Its diversification across various healthcare segments offers insulation against industry …
As great as a quick return is, sometimes, we need to invest in a slow and steady performer. In this case, that stock is Johnson & Johnson (NYSE:JNJ). It’s not a sexy pick and it isn’t going to double your money by the end of the year. …
For long-term shareholders it's been quite the ride, though investors thinking about getting in now might be wondering if J&J's best days are behind it. For those of you currently holding Johnson & Johnson stock, and those of you …
“Caring for the world, one person at a time…inspires and unites the people of Johnson & Johnson. We embrace research and science – bringing innovative ideas, products and services to advance the health and well-being of people. Our …
At Johnson & Johnson, the world’s largest health care company, products or business that aren’t top performers aren’t lasting very long. About 70 percent of sales come from assets that were either No. 1 or No. 2 in their category. Last …
12:36a Consumer confidence fell 0.6% last week according to Roy Morgan & ANZ #au.. 12:35a.@MLBNetwork will have Game 1 of #RedSox-#Astros on Thursday with Bob Costas,.. 12:35a Good to see @RACGP join a proud roll-call of …
George Leong: Johnson & Johnson (NYSE:JNJ), which is one of my favorite long-term stocks for income and dividend-reinvesting investors, just dropped below the $100.00-per-share level and is becoming more attractive each day. This …
Shares of Actelion Ltd.(ALIOF.PK) were gaining around 21 percent in the morning trading after the Swiss biotechnology firm on Thursday agreed to a $30 billion takeover by drug major Johnson & Johnson (JNJ). Immediately prior to the …
JNJ) traded up 2.15% at $136.78. The stock’s 52-week range is $109.32 to $137.08. Volume was about 60% above the daily average of around 5.1 million. Jefferies raised the stock’s rating from Hold to Buy and lifted the price target from …